title: Will identifying or targeting altered marker expression in response to cytotoxic therapy be of prognostic or therapeutic value?
authors.forename: Christopher H
authors.initials: CH
authors.lastname: Crane
authors.forename: Howard D
authors.initials: HD
authors.lastname: Thames
authors.forename: Stanley R
authors.initials: SR
authors.lastname: Hamilton
mesh_terms: D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000096:biosynthesis; D016158:Genes, p53; D006801:Humans; D019394:Ki-67 Antigen / Q000096:biosynthesis; D011379:Prognosis; D012004:Rectal Neoplasms / Q000378:metabolism / Q000628:therapy*
chemical_list: D014408:Biomarkers, Tumor; C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D019394:Ki-67 Antigen